Aurinia Pharmaceuticals Inc.
AUPH
$15.37
$0.191.25%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 73.91% | 47.17% | 14,651.15% | 119.87% | 2,879.64% |
| Total Depreciation and Amortization | -0.62% | -0.82% | 0.04% | -0.57% | 0.43% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -27.13% | 424.53% | -13,241.18% | -55.76% | 136.08% |
| Change in Net Operating Assets | -74.26% | 48.47% | -71.10% | 134.77% | 11.49% |
| Cash from Operations | 18.82% | 2,404.62% | 51.65% | 161.02% | 179.25% |
| Capital Expenditure | 100.00% | -129.41% | 74.38% | -146.43% | 23.44% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 678.64% | -158.10% | -192.86% | -27.96% | 65.77% |
| Cash from Investing | 713.64% | -158.26% | -193.71% | -30.27% | 65.63% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.73% | -31.83% | -15.08% | -16.57% | -6.42% |
| Issuance of Common Stock | 3,352.97% | -92.32% | -3.35% | 394.54% | 29.70% |
| Repurchase of Common Stock | -18.57% | 9.15% | 98.35% | -5,310.18% | -570.55% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 110.83% | -8.81% | 91.80% | -285.38% | -436.61% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,133.99% | -130.55% | -84.83% | 440.48% | 56.76% |